Search Results - "Pneumococcal conjugate vaccine"

Response to article by Matthew Wasserman et al. (2018): "Modeling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico" by Jorge A. Gómez, Adriana Guzman Holst, Javier Nieto

Connect to this object online.

Invasive pneumococcal disease (IPD) in HIV infected patients in Israel since the introduction of pneumococcal conjugated vaccines (PCV): Analysis of a nationwide surveillance study, 2009-2014 by Michal Chowers, Gili Regev-Yochay, Orna Mor, Ronit Cohen-Poradosu, Klaris Riesenberg, Oren Zimhony, Daniel Chemtob, Michal Stein, Ron Dagan, Itzchak Levy

Connect to this object online.

Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in HIV-infected adults in the era of highly active antiretroviral therapy: analysis stratified by CD4 T-cell count by Joon Young Song, Hee Jin Cheong, Ji Yun Noh, Min Joo Choi, Jin Gu Yoon, Woo Joo Kim

Connect to this object online.

Economic burden of acute otitis media, pneumonia, and invasive pneumococcal disease in children in the United States after the introduction of 13-valent pneumococcal conjugate vaccines during 2014-2018 by Tianyan Hu, Yan Song, Nicolae Done, Salini Mohanty, Qing Liu, Eric M. Sarpong, Esteban Lemus-Wirtz, James Signorovitch, Thomas Weiss

Connect to this object online.

Corrigendum to "Decline in childhood respiratory-related mortality after the introduction of the pneumococcal conjugate vaccine in Morocco" [J Infect Public Health 13 (March (3)) (2020) 402-406] by Nada Bennani Mechita, Majdouline Obtel, Abdelilah Elmarnissi, Laila Lahlou, Aziza Lyaghfouri, Imad Cherkaoui, Mustapha Mrabet, Rachid Razine, Redouane Abouqal

Connect to this object online.

A randomized, open-label, phase 3 study evaluating safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in Chinese infants and children under 6 years of age by Kai Chu, Yuemei Hu, Hongxing Pan, Jingliang Wu, Dandan Zhu, Mariano M. Young, Li Luo, Zhuobiao Yi, Peter C. Giardina, William C. Gruber, Daniel A. Scott, Wendy Watson

Connect to this object online.

Pneumonia hospitalizations and mortality in children 3 - 24-month-old in Nigeria from 2013 to 2020: Impact of pneumococcal conjugate vaccine ten valent (PHiD-CV-10) by Jalo Iliya, Denis R. Shatima, Beckie N. Tagbo, Adejumoke I. Ayede, Abieyuwa O. Fagbohun, Aliu Rasaq, Sarah Nalban, Isaac W. Elon, Ramatu Mohammed-Nafiu, Patience Ahmed, Oladapo B. Oyewole, Ayobami A. Bakare, Bidemi O. Yusuf, Olugbenga O. Akinrinoye, William N. Ogala, Adegoke G. Falade

Connect to this object online.

Incidence of invasive pneumococcal disease in children with commercial insurance or Medicaid coverage in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998-2018 by Tianyan Hu, Yan Song, Nicolae Done, Qing Liu, Eric M. Sarpong, Esteban Lemus-Wirtz, James Signorovitch, Salini Mohanty, Thomas Weiss

Connect to this object online.

Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies by Dr. Laura L Hammitt, MD, Donald O Akech, BSc, Susan C Morpeth, FRACP, Angela Karani, BSc, Norbert Kihuha, BSc, Sammy Nyongesa, MSc, Tahreni Bwanaali, MBA, Edward Mumbo, BSc, Tatu Kamau, MPH, Shahnaaz K Sharif, MD, Prof. J Anthony G Scott, FRCP

Connect to this object online.

Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of community-acquired pneumonia and pneumonia-related hospitalizations in children ≤5 years after its implementation into the national immunization program of Turkey by Erdem Gönüllü, Ahmet Soysal, Ismail Yıldız, Gökhan Aydemir, Turan Tunç, Metin Karaböcüoğlu

Connect to this object online.

Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of acute otitis media, recurrent otitis media and tympanostomy tube insertion in children after its implementation into the national immunization program in Turkey by Ahmet Soysal, Erdem Gönüllü, Ismail Yıldız, Gökhan Aydemir, Turan Tunç, Yezdan Fırat, Burak Erdamar, Metin Karaböcüoğlu

Connect to this object online.

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered in a prime-boost regimen among Chinese infants: a randomized, double blind phase III clinical trial by Wenjuan Wang, Qi Liang, Jiahong Zhu, Junxia Zhang, Junsheng Chen, Sulan Xie, Yuemei Hu, Guifan Li

Connect to this object online.

Evaluation of a phased pneumococcal conjugate vaccine introduction in Mongolia using enhanced pneumonia surveillance and community carriage surveys: a study protocol for a prospective observational study and lessons learned by S. F. La Vincente, C. von Mollendorf, M. Ulziibayar, C. Satzke, L. Dashtseren, K. K. Fox, E. M. Dunne, C. D. Nguyen, J. de Campo, M. de Campo, H. Thomson, G. Surenkhand, S. Demberelsuren, S. Bujinlkham, L. A. H. Do, D. Narangerel, T. Cherian, T. Mungun, E. K. Mulholland

Connect to this object online.

Comment on Gomez et. al. "Response to article by Wasserman et. al. (2018) 'Modelling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico'" by Matt Wasserman, Maria Gabriela Palacios, Ana Gabriela Grajales, Michele Wilson, Cheryl McDade, Raymond Farkouh

Connect to this object online.

Nasopharyngeal carriage of Streptococcus pneumoniae among children aged 30 days to <60 months in Beijing and Shenzhen, China (2018-2021) during pneumococcal conjugate vaccine introduction and the coronavirus disease (COVID-19) pandemic by Qianqian Du, Zhaoqiu Liu, Hongmei Wang, Yani Wang, Li Liu, Xuexia Wen, Sangjie Yu, Qingqing Ren, Elisa Gonzalez, Adriano Arguedas, Mark A. Fletcher, Kaijie Pan, Graciela Del Carmen Morales, Jikui Deng, Kaihu Yao

Connect to this object online.

Experience of Vaccination of a Patient with Systemic Juvenile Idiopathic Arthritis (sJIA) with a 13-Valent Pneumococcal Conjugate Vaccine, prior to the Appointment of Therapy with Tocilizumab, an Anti-IL-6-Receptor Monoclonal Antibody by Daria D. Vankova, Ekaterina I. Alekseeva, Margarita А. Soloshenko, Tatiana М. Dvoriakovskaia, Ksenia B. Isaeva, Rina V. Denisova, Anna V. Mamutova, Mariya G. Rudnitskaya, Nikolay A. Mayansky, Natal'ya Е. Tkachenko

Connect to this object online.

An indirect treatment comparison (ITC) and matching-adjusted indirect comparison (MAIC) between a 15-valent (V114) and a 20-valent (PCV20) pneumococcal conjugate vaccine among healthy infants by Shahrul Mt-Isa, Justin R. Chumbley, Emma L. Crawford, Natalie Banniettis, Ulrike K. Buchwald, Jessica Weaver, Thomas Weiss

Connect to this object online.

Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006-18: prospective observational time-series and case-control studies by Naor Bar-Zeev, PhD, Todd D Swarthout, MSc, Dean B Everett, ProfPhD, Maaike Alaerts, PhD, Jacquline Msefula, BSc, Comfort Brown, Dipl, Sithembile Bilima, BSc, Jane Mallewa, MD, Carina King, PhD, Anne von Gottberg, ProfPhD, Jennifer R Verani, MD, Cynthia G Whitney, MD, Charles Mwansambo, FRCPCH, Stephen B Gordon, ProfPhD, Nigel A Cunliffe, ProfPhD, Neil French, ProfPhD, Robert S Heyderman, ProfPhD

Connect to this object online.

Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU) by Randall Severance, Howard Schwartz, Ron Dagan, Laurie Connor, Jianing Li, Alison Pedley, Jonathan Hartzel, Tina M. Sterling, Katrina M. Nolan, Gretchen M. Tamms, Luwy K. Musey, Ulrike K. Buchwald, for the V114-021 (PNEU-FLU)

Connect to this object online.

A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen in healthy infants in South Korea (PNEU-PED-KOR) by Alvino Maestri, Su Eun Park, Fiona Fernandes, Zhongyi "Lucy" Li, Yae-Jean Kim, Yun-Kyung Kim, Jin Lee, Ji Young Park, Dong Hyun Kim, GyongSeon Yang, Hyunjung Lim, Jin Oh Kim, Robert Lupinacci, Tina M. Sterling, Marissa Wilck, Alejandra Esteves-Jaramillo, Natalie Banniettis

Connect to this object online.